Trademark: 88605778
Word
ZELMYNDIS CELL THERAPY
Status
Dead
Status Code
602
Status Date
Thursday, July 2, 2020
Serial Number
88605778
Mark Type
4000
Filing Date
Thursday, September 5, 2019
Abandoned Date
Tuesday, June 16, 2020

Trademark Owner History

Classifications
5 stem cells for scientific and medical research; stem cells for medical or clinical use; pharmaceutical compositions comprising stem cells; pharmaceutical compositions comprising stem cells for the treatment of neurological, cardiovascular, inflammatory and immune diseases, critical care disorders, conditions and injuries, solid organ transplantation, wound healing and orthopedics

Trademark Events
Oct 1, 2021
Applicant/Correspondence Changes (Non-Responsive) Entered
Oct 1, 2021
Teas Change Of Correspondence Received
Oct 1, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 1, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 1, 2021
Teas Change Of Owner Address Received
Oct 8, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
Oct 8, 2020
Teas Change Of Correspondence Received
Oct 8, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 8, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 8, 2020
Teas Change Of Owner Address Received
Jul 6, 2020
Abandonment Notice E-Mailed - Failure To Respond
Jul 2, 2020
Abandonment - Failure To Respond Or Late Response
Dec 14, 2019
Notification Of Non-Final Action E-Mailed
Dec 14, 2019
Non-Final Action E-Mailed
Dec 14, 2019
Non-Final Action Written
Dec 7, 2019
Assigned To Examiner
Sep 17, 2019
New Application Office Supplied Data Entered In Tram
Sep 9, 2019
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24